citalopram has been researched along with Neurotic Disorders in 4 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fiedorowicz, JG | 1 |
Hale, N | 1 |
Spector, AA | 1 |
Coryell, WH | 1 |
Milinevskiĭ, IV | 1 |
Shabaldina, EV | 1 |
Shamova, IP | 1 |
Shabaldin, AV | 1 |
Talarowska, M | 1 |
Zboralski, K | 1 |
Chamielec, M | 1 |
Gałecki, P | 1 |
Knorr, U | 1 |
Vinberg, M | 1 |
Mortensen, EL | 1 |
Winkel, P | 1 |
Gluud, C | 1 |
Wetterslev, J | 1 |
Gether, U | 1 |
Kessing, LV | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Associations Between Gene-Polymorphisms, Endo-Phenotypes for Depression and Antidepressive Treatment (AGENDA)[NCT00386841] | Phase 4 | 80 participants (Actual) | Interventional | 2007-04-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 trials available for citalopram and Neurotic Disorders
Article | Year |
---|---|
Neuroticism but not omega-3 fatty acid levels correlate with early responsiveness to escitalopram.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Character; Citalopram; Depressiv | 2010 |
[The use of the antidepressant citalopran for the treatment of chronic pharyngitis and pharyngeal neurosis].
Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Citalopram; Dose-Response Relation | 2011 |
Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial.
Topics: Adolescent; Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Emotions; Family H | 2012 |
1 other study available for citalopram and Neurotic Disorders
Article | Year |
---|---|
The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Hypochond | 2011 |